Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: Robin who wrote (3413)	6/23/1998 8:59:00 PM
From: JanyBlueEyes	Read Replies (2) \| Respond to of 5736

Robin <<I tend to look at the fundamentals of a company>> YOU tend to look at the fundamentals of the company??? (what a joke - only people who have read this board know why this is funny) <<CCSI has little cash>> From sec.gov Current assets: Cash and cash equivalents = $ 4,735,216 <<a product with no buyer>> See Message 4963834 : Chromatics Color Sciences Signs Memorandum of Understanding with China's International Health Exchange Center, Ministry of Health Also Announces Letter of Intent With China National Medical Equipment and Supplies Import and Export Corporation, Ministry of Health ALSO: From Message 4821987 CCSI MEDICAL DEVICE MARKETING Prior to FDA clearance, CCSI disclosed in its public filings that the Company intended to market its Colormate(TM) TLc-BiliTest(TM) by way of strategic alliance with regional distributors, since the preliminary terms proposed by larger medical distributors were not as beneficial to the Company. However, after FDA clearance, CCSI was given business proposals from a number of large international medical companies with global distribution and was offered better terms. CCSI discussed these earlier proposals and many of them included manufacturing capabilities by the distribution partner. Various structures, some very complex, were involved. In late November, 1997, CCSI signed an agreement retaining Mr. Fred Frank, Vice Chairman of Lehman Brothers to assist in the distribution negotiations. After Mr. Frank's involvement, additional, larger medical companies made offers to CCSI, and certain of these companies then commenced due diligence and entered negotiations. However, the later companies' business proposals proved significantly more attractive than the earlier proposals. CCSI also began the process of preparing the necessary manufacturing regulatory and other manufacturing related activities that are required to deliver medical devices. In April CCSI announced that it was in late-stage negotiations to reach definitive agreements for global distribution and that it would be launching the Colormate(TM) TLc-BiliTest(TM) at the Pediatric Academic Societies annual conference and exhibition where Dr. Ian Holzman was invited to present his medical paper on the Colormate(TM) TLc-BiliTest(TM) clinical studies. Over 4000 participants attend this conference annually. The response to the Colormate(TM) TLc-BiliTest(TM) launch at the P.A.S. was unusually high. Over 486 written responses at the P.A.S. and over 100 since the P.A.S. have been received by the Company, many requesting information on ordering the device. CCSI has continued negotiations over the past month. <<and a lot of missed commitments>> Please find me one piece of information that states a commitment that was missed, I can't seem to find one. <<not to mention no insider buying and a lot of selling>> There has been no insider selling since December 1997. techstocks.com <<I consider these red flags>> Think again.